0001572426-15-000080.txt : 20150716
0001572426-15-000080.hdr.sgml : 20150716
20150716185051
ACCESSION NUMBER: 0001572426-15-000080
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150715
FILED AS OF DATE: 20150716
DATE AS OF CHANGE: 20150716
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nexvet Biopharma plc
CENTRAL INDEX KEY: 0001618561
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: NATL INST FOR BIOPROCESSING RESEARCH
STREET 2: FOSTERS AVENUE, MOUNT MERRION
CITY: BLACKROCK CO. DUBLIN
STATE: L2
ZIP: 00000
BUSINESS PHONE: 353 1 215 8100
MAIL ADDRESS:
STREET 1: NATL INST FOR BIOPROCESSING RESEARCH
STREET 2: FOSTERS AVENUE, MOUNT MERRION
CITY: BLACKROCK CO. DUBLIN
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: NEXVET BIOPHARMA Ltd
DATE OF NAME CHANGE: 20140903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wald Graeme
CENTRAL INDEX KEY: 0001632455
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36828
FILM NUMBER: 15992386
MAIL ADDRESS:
STREET 1: C/O NEXVET BIOPHARMA PLC
STREET 2: NATL INST, FOSTERS AVENUE, MOUNT MERRION
CITY: BLACKROCK
STATE: L2
ZIP: 00000
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-07-15
1
0001618561
Nexvet Biopharma plc
NVET
0001632455
Wald Graeme
C/O NEXVET BIOPHARMA PLC
NIBRT; FOSTERS AVENUE; MOUNT MERRION
BLACKROCK
L2
IRELAND
1
0
0
0
Ordinary Shares
2015-07-15
4
M
0
3600
.125
A
3600
D
Ordinary Shares
6176
I
Wald Funds Pty Ltd <Wald Funds Unit A/C>
Ordinary Shares
7548
I
JanCutz Pty Ltd <Emuna Superannuation Fund A/C>
Options to Purchase Shares
.125
2015-07-15
4
M
0
3600
0
D
2014-09-30
2019-07-01
Ordinary Shares
3600
0
D
The reporting person has sole voting and dispositive power with respect to these reported securities.
The option to purchase shares vested and became exercisable as to 25% of the grant on each of 9/30/14, 12/31/14, 3/31/15 and 6/30/15.
/s/ Graeme David Wald by Geraldine Farrell, Attorney-in-Fact
2015-07-15